About Medico Remedies Limited
Data last updated: 09 January 2026
Medico Remedies Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 18 March 1994, the company has been in operation for over 32 years.
Registered with ROC Mumbai under CIN L24230MH1994PLC077187. Listed on BSE: 540937.
Capital: an authorised share capital of ₹17 Cr and a paid-up capital of ₹16.6 Cr. Formerly known as Medico Remedies P Ltd and Medico Remedies Private Limited. It is led by directors including Rita Haresh Mehta and Haresh Kapurlal Mehta.
Last AGM: 08 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per NSE-filed standalone financials for FY 2026, the company reported a revenue of ₹206.38 Cr, a growth of 36.73% compared to the previous year. The net worth stands at ₹75.47 Cr (up 21.16% YoY). Total assets are valued at ₹153.4 Cr (up 28.24% YoY).
The company has a workforce of approximately 70 employees as per the latest available data.
The company is associated with 2 brands - Medico Remedies, Medicoremedies. As per MCA filings, the company has open charges of ₹54.16 Cr and satisfied charges of ₹39.66 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicoremediesindia.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address1105/1106 11Th Floor Hubtown Solaris Opp. Telli Galli N S Phadke Marg Andhe, Ri East, Mumbai, Maharashtra, India – 400069
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Medico Remedies Limited
Medico Remedies Limited has undergone 2 name changes throughout its history. The company was previously known as Medico Remedies P Ltd, and Medico Remedies Private Limited. The current legal name is Medico Remedies Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Medico Remedies Limited | Current |
| Medico Remedies P Ltd | Previous |
| Medico Remedies Private Limited | Previous |
CIN History of Medico Remedies Limited
Medico Remedies Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24230MH1994PLC077187, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230MH1994PLC077187 | Current |
| U24230MH1994PLC077187 | Previous |
| U24230MH1994PTC077187 | Previous |
Associated Brands with Medico Remedies Limited
Medico Remedies Limited operates two associated brands: Medico Remedies and Medicoremedies. These brands represent Medico Remedies Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations are manufactured by Medico Remedies. | medicoremediesindia.com | |
| Pharmaceutical formulations are manufactured, emphasizing anti-infectives and therapeutic drugs. | medicoremedies.com |
Business Activity of Medico Remedies Limited
Medico Remedies Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Medico Remedies Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Medico Remedies Limited
Medico Remedies Limited is audited by Shah Shroff & Associates (ICAI peer reviewed, certificate valid till 2028-04-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Shah Shroff & Associates (ICAI peer reviewed, certificate valid till 2028-04-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Medico Remedies Limited
Medico Remedies Limited is currently managed by 10 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rita Haresh Mehta
Also directs:
Medico Remedies Limited
|
Director | 08 Dec 1999 | 26 Years 7 Months | Current |
|
Haresh Kapurlal Mehta
Also directs:
Medico Remedies Limited
|
Whole-Time Director | 18 Mar 1994 | 32 Years 3 Months | Current |
|
Harshit Haresh Mehta
Also directs:
Medico Remedies Limited
|
Managing Director | 14 Dec 2011 | 14 Years 7 Months | Current |
|
Rishit Hareshbhai Mehta
Also directs:
Medico Remedies Limited
|
Whole-Time Director | 12 Mar 2015 | 11 Years 4 Months | Current |
|
Deepak Maganlal Vekaria
Also directs:
Medico Remedies Limited
|
Director | 25 Sep 2017 | 8 Years 9 Months | Current |
| Bharat Nathalal Rathod | Director | 25 Sep 2017 | 8 Years 9 Months | Current |
Financials of Medico Remedies Limited FY 2026 filings available
Medico Remedies Limited reported revenue of ₹206.38 Cr (up 36.73% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹206.38 Cr | ₹150.94 Cr | ₹144.92 Cr | ₹140.44 Cr |
| Other Income | ₹5.93 Cr | ₹2.69 Cr | ₹2.13 Cr | ₹3.95 Cr |
| Total Income | ₹212.31 Cr | ₹153.63 Cr | ₹147.05 Cr | ₹144.38 Cr |
| Cost of Materials Consumed | ₹148.59 Cr | ₹111.39 Cr | ₹106.1 Cr | ₹100.07 Cr |
| Purchases of Stock-in-Trade | ₹4.41 Cr | ₹2.1 Cr | ₹1.77 Cr | ₹5.98 Cr |
| Changes in Inventories | -₹1.67 Cr | -₹5.16 Cr | ₹2.04 Cr | -₹1.18 Cr |
| Employee Benefit Expense | ₹7.4 Cr | ₹6.28 Cr | ₹5.92 Cr | ₹5.68 Cr |
| Finance Costs | ₹1.81 Cr | ₹1.16 Cr | ₹82.35 Lakh | ₹74.71 Lakh |
| Depreciation & Amortisation | ₹3.09 Cr | ₹3.03 Cr | ₹2.88 Cr | ₹2.72 Cr |
| Other Expenses | ₹30.62 Cr | ₹21.33 Cr | ₹16.18 Cr | ₹20.27 Cr |
| Total Expenses | ₹194.25 Cr | ₹140.13 Cr | ₹135.71 Cr | ₹134.29 Cr |
| Profit Before Exceptional Items & Tax | ₹18.06 Cr | ₹13.5 Cr | ₹11.34 Cr | ₹10.1 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹18.06 Cr | ₹13.5 Cr | ₹11.34 Cr | ₹10.1 Cr |
| Total Tax Expense | ₹4.94 Cr | ₹3.41 Cr | ₹3.04 Cr | ₹2.86 Cr |
| Net Profit | ₹13.12 Cr | ₹10.09 Cr | ₹8.29 Cr | ₹7.24 Cr |
| Other Comprehensive Income | -₹10.96 Lakh | ₹47,000 | ₹23.7 Lakh | ₹2.69 Lakh |
| Total Comprehensive Income | ₹13.01 Cr | ₹10.1 Cr | ₹8.53 Cr | ₹7.27 Cr |
| EBITDA (computed) | ₹22.96 Cr | ₹17.69 Cr | ₹15.04 Cr | ₹13.57 Cr |
| Basic EPS | ₹1.58 | ₹1.22 | ₹1.00 | ₹0.87 |
| Diluted EPS | ₹1.58 | ₹1.22 | ₹1.00 | ₹0.87 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹153.4 Cr | ₹119.62 Cr | ₹96.2 Cr | ₹87.45 Cr |
| Non-current Assets | ₹24.49 Cr | ₹22.95 Cr | ₹22.43 Cr | ₹22.91 Cr |
| Current Assets | ₹128.92 Cr | ₹96.68 Cr | ₹73.76 Cr | ₹64.54 Cr |
| Property, Plant & Equipment | ₹20.1 Cr | ₹20.53 Cr | ₹20.27 Cr | ₹20.31 Cr |
| Inventories | ₹30.02 Cr | ₹26.73 Cr | ₹16.34 Cr | ₹19.7 Cr |
| Trade Receivables | ₹81.99 Cr | ₹57.18 Cr | ₹49.63 Cr | ₹36.09 Cr |
| Cash & Equivalents | ₹1.91 Cr | ₹1.09 Cr | ₹18.27 Lakh | ₹91.14 Lakh |
| Equity (Net Worth) | ₹75.47 Cr | ₹62.29 Cr | ₹52.37 Cr | ₹43.84 Cr |
| Equity Share Capital | ₹16.6 Cr | ₹16.6 Cr | ₹16.6 Cr | ₹16.6 Cr |
| Borrowings (Non-current) | ₹28.63 Lakh | ₹36.88 Lakh | ₹86.72 Lakh | ₹1.55 Cr |
| Borrowings (Current) | ₹18.55 Cr | ₹14.33 Cr | ₹7.18 Cr | ₹8.22 Cr |
| Total Debt (computed) | ₹18.84 Cr | ₹14.7 Cr | ₹8.05 Cr | ₹9.76 Cr |
| Current Liabilities | ₹77.64 Cr | ₹56.96 Cr | ₹42.81 Cr | ₹41.52 Cr |
| Total Liabilities | ₹77.93 Cr | ₹57.33 Cr | ₹43.82 Cr | ₹43.61 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹5.87 Cr | ₹4.89 Cr | ₹2.44 Cr | ₹8.17 Cr |
| Investing Cash Flow | -₹4.51 Cr | -₹3.46 Cr | -₹2.68 Cr | -₹6.6 Cr |
| Financing Cash Flow | -₹55 Lakh | -₹52 Lakh | -₹49 Lakh | -₹1.82 Cr |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | ₹5.87 Cr | ₹4.89 Cr | ₹2.44 Cr | ₹8.17 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹81.2 Lakh | ₹91.24 Lakh | -₹72.86 Lakh | -₹25.35 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹56.81 Cr | ₹58.68 Cr | ₹52.64 Cr | ₹38.25 Cr | ₹41.3 Cr | ₹39.49 Cr | ₹39.35 Cr | ₹30.8 Cr | ₹41.32 Cr | ₹29.77 Cr | ₹42.36 Cr | ₹31.47 Cr |
| Other Income | ₹2.87 Cr | ₹67.68 Lakh | ₹1.72 Cr | ₹65.81 Lakh | ₹29.3 Lakh | ₹1.43 Cr | ₹67.82 Lakh | ₹29.32 Lakh | ₹58.43 Lakh | ₹27.28 Lakh | ₹95.71 Lakh | ₹31.43 Lakh |
| Total Income | ₹59.68 Cr | ₹59.36 Cr | ₹54.36 Cr | ₹38.91 Cr | ₹41.6 Cr | ₹40.91 Cr | ₹40.03 Cr | ₹31.09 Cr | ₹41.91 Cr | ₹30.05 Cr | ₹43.31 Cr | ₹31.78 Cr |
| Cost of Materials Consumed | ₹40.34 Cr | ₹36.18 Cr | ₹43.35 Cr | ₹28.71 Cr | ₹29.42 Cr | ₹30.93 Cr | ₹28.49 Cr | ₹22.55 Cr | ₹29.65 Cr | ₹24.26 Cr | ₹29.75 Cr | ₹22.44 Cr |
| Purchases of Stock-in-Trade | ₹45.59 Lakh | ₹2.21 Cr | ₹1.12 Cr | ₹62.46 Lakh | ₹55.86 Lakh | ₹33.39 Lakh | ₹68.11 Lakh | ₹52.34 Lakh | ₹71.02 Lakh | ₹50.28 Lakh | -₹7.37 Lakh | ₹63.14 Lakh |
| Changes in Inventories | -₹1.36 Cr | ₹5.71 Cr | -₹4.02 Cr | -₹2 Cr | -₹2.61 Cr | -₹2.6 Cr | ₹1.08 Cr | -₹1.02 Cr | ₹2.96 Lakh | -₹3.21 Cr | ₹4.4 Cr | ₹81.2 Lakh |
| Employee Benefit Expense | ₹1.76 Cr | ₹2.13 Cr | ₹1.81 Cr | ₹1.7 Cr | ₹1.58 Cr | ₹1.88 Cr | ₹1.38 Cr | ₹1.44 Cr | ₹1.36 Cr | ₹1.72 Cr | ₹1.48 Cr | ₹1.36 Cr |
| Finance Costs | ₹90.38 Lakh | ₹38.63 Lakh | ₹23.51 Lakh | ₹28.11 Lakh | ₹49.4 Lakh | ₹27.62 Lakh | ₹21.18 Lakh | ₹17.65 Lakh | ₹24.7 Lakh | ₹22.25 Lakh | ₹18.21 Lakh | ₹17.18 Lakh |
| Depreciation & Amortisation | ₹80.19 Lakh | ₹79.02 Lakh | ₹73.36 Lakh | ₹76.9 Lakh | ₹76.56 Lakh | ₹76.41 Lakh | ₹74.82 Lakh | ₹75.22 Lakh | ₹73.79 Lakh | ₹71.97 Lakh | ₹70.78 Lakh | ₹71.4 Lakh |
| Other Expenses | ₹8.46 Cr | ₹8.11 Cr | ₹7.66 Cr | ₹6.38 Cr | ₹5.69 Cr | ₹5.84 Cr | ₹5.31 Cr | ₹4.49 Cr | ₹4.92 Cr | ₹3.76 Cr | ₹3.72 Cr | ₹3.78 Cr |
| Total Expenses | ₹51.36 Cr | ₹55.53 Cr | ₹50.89 Cr | ₹36.48 Cr | ₹35.9 Cr | ₹37.42 Cr | ₹37.9 Cr | ₹28.92 Cr | ₹37.66 Cr | ₹27.98 Cr | ₹40.17 Cr | ₹29.9 Cr |
| Profit Before Exceptional Items & Tax | ₹8.32 Cr | ₹3.83 Cr | ₹3.47 Cr | ₹2.43 Cr | ₹5.7 Cr | ₹3.5 Cr | ₹2.13 Cr | ₹2.18 Cr | ₹4.25 Cr | ₹2.06 Cr | ₹3.14 Cr | ₹1.88 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹8.32 Cr | ₹3.83 Cr | ₹3.47 Cr | ₹2.43 Cr | ₹5.7 Cr | ₹3.5 Cr | ₹2.13 Cr | ₹2.18 Cr | ₹4.25 Cr | ₹2.06 Cr | ₹3.14 Cr | ₹1.88 Cr |
| Total Tax Expense | ₹2.46 Cr | ₹96 Lakh | ₹90.59 Lakh | ₹61.59 Lakh | ₹1.36 Cr | ₹87.82 Lakh | ₹57.83 Lakh | ₹59.63 Lakh | ₹1.15 Cr | ₹61.76 Lakh | ₹71.75 Lakh | ₹56.3 Lakh |
| Net Profit | ₹5.86 Cr | ₹2.87 Cr | ₹2.57 Cr | ₹1.82 Cr | ₹4.34 Cr | ₹2.62 Cr | ₹1.55 Cr | ₹1.58 Cr | ₹3.1 Cr | ₹1.45 Cr | ₹2.43 Cr | ₹1.32 Cr |
| Other Comprehensive Income | -₹11.32 Lakh | ₹12,000 | -₹12,000 | ₹12,000 | -₹20,000 | ₹23,000 | ₹22,000 | ₹22,000 | ₹21.82 Lakh | ₹63,000 | ₹63,000 | ₹63,000 |
| Total Comprehensive Income | ₹5.74 Cr | ₹2.87 Cr | ₹2.57 Cr | ₹1.82 Cr | ₹4.34 Cr | ₹2.62 Cr | ₹1.56 Cr | ₹1.58 Cr | ₹3.32 Cr | ₹1.45 Cr | ₹2.43 Cr | ₹1.33 Cr |
| EBITDA (computed) | ₹10.03 Cr | ₹5.01 Cr | ₹4.44 Cr | ₹3.48 Cr | ₹6.96 Cr | ₹4.54 Cr | ₹3.09 Cr | ₹3.1 Cr | ₹5.23 Cr | ₹3.01 Cr | ₹4.03 Cr | ₹2.77 Cr |
| Basic EPS | ₹0.71 | ₹0.35 | ₹0.31 | ₹0.22 | ₹0.52 | ₹0.32 | ₹0.19 | ₹0.19 | ₹0.37 | ₹0.17 | ₹0.29 | ₹0.16 |
| Diluted EPS | ₹0.71 | ₹0.35 | ₹0.31 | ₹0.22 | ₹0.52 | ₹0.32 | ₹0.19 | ₹0.19 | ₹0.37 | ₹0.17 | ₹0.29 | ₹0.16 |
Shareholding Pattern of Medico Remedies Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 61.38%, foreign institutional investors hold 0.03%, retail and other public shareholders hold 38.59% of Medico Remedies Limited. The company had 16,189 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 61.38% | 61.38% | 61.38% | 62.59% | 63.79% | 66.83% |
| Public | 38.62% | 38.62% | 38.62% | 37.41% | 36.21% | 33.17% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Promoters | 61.38% | 63.79% | 73.34% | 73.34% |
| Public | 38.62% | 36.21% | 26.66% | 26.66% |
| Promoter change (YoY, %pts) | -2.41 | -9.55 | +0.00 | - |
Board & Governance of Medico Remedies Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Medico Remedies Limited has 10 directors - 5 independent and 4 executive. The board is chaired by HARESH KAPURLAL MEHTA.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| HARESH KAPURLAL MEHTA | Executive Director · Chairperson | 1994-03-18 | 1 |
| HARSHIT HARESH MEHTA | Executive Director · MD | 2011-12-14 | 1 |
| RISHIT HARESHBHAI MEHTA | Executive Director | 2015-03-12 | 1 |
| RITA HARESH MEHTA | Non-Executive - Non Independent Director | 1999-12-08 | 1 |
| DEEPAK MAGANLAL VEKARIA | Non-Executive - Independent Director | 2017-09-25 | 1 |
| BHARAT NATHALAL RATHOD | Non-Executive - Independent Director | 2017-09-25 | 1 |
| DEEPESH RAJESH SHAH | Non-Executive - Independent Director | 2022-04-22 | 1 |
| KUNAL TUSHAR VORA | Non-Executive - Independent Director | 2024-08-13 | 1 |
| MAHESHKUMAR DARJI | Executive Director | 2025-07-30 | 1 |
| ANUJ KISHORE MODY | Non-Executive - Independent Director | 2024-11-12 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | DEEPAK MAGANLAL VEKARIA (Chairperson), HARESH KAPURLAL MEHTA, BHARAT NATHALAL RATHOD, KUNAL TUSHAR VORA |
| Nomination and remuneration committee | DEEPAK MAGANLAL VEKARIA (Chairperson), BHARAT NATHALAL RATHOD, KUNAL TUSHAR VORA |
| Stakeholders Relationship Committee | BHARAT NATHALAL RATHOD (Chairperson), HARSHIT HARESH MEHTA, RISHIT HARESHBHAI MEHTA |
Charges & Borrowings of Medico Remedies Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2018 | Others | ₹24.08 Cr | Open |
| 31 Jul 2018 | Others | ₹30.08 Cr | Open |
| 31 Aug 2019 | Others | ₹2.75 Cr | Satisfied |
| 31 Aug 2019 | Others | ₹2.75 Cr | Satisfied |
| 19 Oct 2002 | Bank of Baroda | ₹1.49 Cr | Satisfied |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Medico Remedies Limited
Medico Remedies Limited has a workforce of 70 employees as of Apr 09, 2024.
Employee and EPFO history for Medico Remedies Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Medico Remedies Limited
GST registrations and filing compliance for Medico Remedies Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Medico Remedies Limited
Credit ratings, litigation, and regulatory alerts for Medico Remedies Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medico Remedies Limited
MSME payment history for Medico Remedies Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medico Remedies Limited
Corporate group structure for Medico Remedies Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medico Remedies Limited
MCA filings and documents for Medico Remedies Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Medico Remedies Limited
Recent News on Medico Remedies Limited
Frequently Asked Questions about Medico Remedies Limited
Medico Remedies Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 18 March 1994 (32+ years old) and is registered under CIN L24230MH1994PLC077187. Listed on BSE: 540937. The company has 70 employees.
Medico Remedies Limited reported revenue of ₹206.38 Cr for FY 2026 (up 36.73% YoY) based on standalone NSE filings.
The current directors of Medico Remedies Limited are:
- Rita Haresh Mehta - Director
- Haresh Kapurlal Mehta - Whole-Time Director
- Harshit Haresh Mehta - Managing Director
- Rishit Hareshbhai Mehta - Whole-Time Director
- Deepak Maganlal Vekaria - Director
- Bharat Nathalal Rathod - Director
- Deepesh Rajesh Shah - Director
- Maheshkumar Rameshchandra Darji - Director
- Anuj Kishore Mody - Director
- Kunal Tushar Vora - Director
The primary industry of Medico Remedies Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Medico Remedies Limited is listed on BSE with code 540937.
Medico Remedies Limited can be reached at the registered office: 11051106 11Th Floor Hubtown Solaris Opp. Telli Galli N S Phadke Marg Andhe, Ri East, Mumbai, Maharashtra, India – 400069, or through the website medicoremediesindia.com.